GAM
NXTM

Gotham Asset Management’s NxStage Medical Inc. NXTM Stock Holding History

Gotham Asset Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-18,781
Closed -$407K – 1107
2016
Q2 		$407K Buy
+18,781
New +$335K ﹤0.01% 761

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Gotham Asset Management's NXTM Position: Q3 2016 in Review

Gotham Asset Management sold out of NxStage Medical Inc. (NXTM) in Q3 2016, closing a stake of 18,781 shares — an estimated $407K sold.

Gotham Asset Management first reported a position in NXTM in Q2 2016 and held it in 1 quarter. The position peaked at $407K in Q2 2016. 156 funds tracked by Wall St. Rank hold NXTM as of Q3 2016.

  • Gotham Asset Management reported no remaining NxStage Medical Inc. position as of Q3 2016 after selling out during the quarter.
  • Gotham Asset Management sold 18,781 NxStage Medical Inc. shares in Q3 2016, an estimated $407K.
  • Gotham Asset Management first reported a position in NxStage Medical Inc. in Q2 2016 and held it in 1 quarter.
  • Gotham Asset Management's NxStage Medical Inc. position peaked at $407K in Q2 2016.
  • 156 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2016.

Based on Gotham Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.